Business Context and Reporting Period
This Form 8-K Current Report was filed by iRhythm Technologies, Inc. (NASDAQ: IRTC) on July 3, 2025, with the earliest event reported on the same date. The filing addresses significant changes to the composition of the Company's Board of Directors.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. The document focuses exclusively on corporate governance changes and director compensation arrangements.
Material Changes
- Resignations: Mark Rubash and Ralph Snyderman notified the Company of their resignations from the Board of Directors, effective July 7, 2025. Both resignations were not based on any disagreement with the Company.
- Appointments: Effective July 7, 2025, the Board appointed Karen McGinnis and Kevin O'Boyle as directors.
- Committee Assignments: Both new directors were appointed to the Audit Committee. Kevin O'Boyle was additionally appointed to the Nominating and Corporate Governance Committee.
- Independence: The Board determined that both Ms. McGinnis and Mr. O'Boyle qualify as independent directors under SEC and Nasdaq standards.
Compensation and Governance Details
Upon appointment, Ms. McGinnis and Mr. O'Boyle received the following compensation under the Director Compensation Policy:
- Initial Equity Grant: Restricted stock units (RSUs) with a fair value of $300,000, vesting annually over three years starting July 7, 2025. These grants accelerate in full upon a change of control if the director remains in service.
- Cash Retainer: $55,000 per year for Board service and $10,000 per year for Audit Committee service, paid quarterly in arrears.
- Additional Committee Fee: Mr. O'Boyle receives an additional $5,000 per year for service on the Nominating and Corporate Governance Committee.
- Future Grants: An anticipated RSU grant with a fair value of $185,000 is expected at the 2026 Annual Meeting, vesting on the date of the first annual stockholder meeting thereafter.
Investor Verification Checklist
- Verify the effective date of the Board composition changes (July 7, 2025).
- Confirm the independence status of the new directors (Karen McGinnis and Kevin O'Boyle) per Nasdaq listing standards.
- Review the specific vesting terms and change-of-control acceleration provisions for the $300,000 initial RSU grants.
- Check for any undisclosed disagreements or material transactions involving the departing directors (Mark Rubash and Ralph Snyderman).